DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20213107

High grade endometrial stromal sarcoma: a clinician dilemma

Poojan Dogra, Shuchi Sharma, Reena Sharma, Suraj Bhardwaj

Abstract


Uterine sarcomas are relatively rare tumors of mesodermal origin. ESS occurs primarily in perimenopausal women in 4th and 5th decade of their life; about one third occurs in postmenopausal women. Here in we describe a case of 44 years old patient presented with one month history of foul smelling discharge per vagina and a pelvic mass. Ultrasound and MRI gave possibility of a large anterior wall and fundal fibroid with degeneration versus neoplastic endometrial thickening. The patient underwent exploratory laparotomy with total abdominal hysterectomy with bilateral salpingoophorectomy with pelvic lymphadenectomy. Histopathology showed tumor cells with round to oval nuclei with high mitotic activity, blood vessel proliferation between the tumor cells and extensive lymphovascular invasion. The pathological diagnosis was HG-ESS stage IB. The patient was referred to radiotherapy department for adjuvant therapy. HG-ESS is a rare clinical entity and considered as important differential diagnosis.


Keywords


HG-ESS, Mesenchymal, Uterine sarcoma

Full Text:

PDF

References


Hosh M, Antar S, Nazzal A. Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int J Gynecol Cancer. 2016;26:1098-104.

Brook SE, Zhan M. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol. 2004;93:204-8.

Abeler VM, Royne O, Thoresen S. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathol. 2009;54:355-64.

Nordal RR, Thoresen SO. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer. 1997;33:907-11.

Wang X, Khoo US, Xue WC. Cervical and peritoneal fluid cytology of uterine sarcomas. Acta Cytol. 2002;46:465-9.

Wei-Cheng Xue, Annie N.Y. Cheung .Best Practice & Research. Clin Obstet Gynaecol. 2011;25(6):719-32.

Berek JS. Uterine cancer. In: Rinehart RD. Hengst TC.editors. Berek & Novak Gynecology 14th ed. 2007:1382-8.

JA Raauh-Hain, Carmen MG. Endometrial stromal sarcoma: a systematic review”, Obstetrics & Gynaecology, 2013;122(3):676-83.

Ali RH, Rouzbahman H. Endometrial stromal tumors revisited: An update based on the2014 WHO classification. J clin Pathol. 2015;68(5):325-32.

CH Lee, RH Ali, M Rouzbahman. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol. 2012;36(10):1562-70.

Lee CH, Mariño-Enriquez A, Ou W. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: A histologically high-grade and clinically aggressive tumor. Am J Surg Pathol. 2012;36(5):641-53.

Hemming ML, Wagner AJ, Nucci MR. YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy. Gynecol Oncol. 2012;145(3):531-5.